These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37829854)

  • 1. Retracted: A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1.
    Intelligence And Neuroscience C
    Comput Intell Neurosci; 2023; 2023():9798269. PubMed ID: 37829854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.
    Tian Y; Zhao L; Wang Y; Zhang H; Xu D; Zhao X; Li Y; Li J
    Asian J Androl; 2016; 18(4):607-12. PubMed ID: 26698234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Potential Prognostic Biomarker for Glioma: Aldo-Keto Reductase Family 1 Member B1.
    Zhao H; Dong X; Huang T; Li X
    Comput Intell Neurosci; 2022; 2022():9979200. PubMed ID: 35341178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer.
    Hojnik M; Šuster NK; Smrkolj Š; Sisinger D; Grazio SF; Verdenik I; Rižner TL
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human dehydrogenase/reductase SDR family member 11 (DHRS11) and aldo-keto reductase 1C isoforms in comparison: Substrate and reaction specificity in the reduction of 11-keto-C
    Endo S; Morikawa Y; Kudo Y; Suenami K; Matsunaga T; Ikari A; Hara A
    J Steroid Biochem Mol Biol; 2020 May; 199():105586. PubMed ID: 31926269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.
    Ireland LS; Harrison DJ; Neal GE; Hayes JD
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):21-34. PubMed ID: 9576847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives.
    Liu J; Wen G; Cao D
    Recent Pat Anticancer Drug Discov; 2009 Nov; 4(3):246-53. PubMed ID: 19522700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial microRNA mediated silencing of cyclase and aldo-keto reductase genes reveal their involvement in the plumbagin biosynthetic pathway.
    Vasav AP; Meshram BG; Pable AA; Barvkar VT
    J Plant Res; 2023 Jan; 136(1):47-62. PubMed ID: 36227455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Aldo-Keto Reductase Family 1 Member B10 as a Biomarker Performs Well in the Diagnosis of Nonalcoholic Steatohepatitis and Fibrosis.
    Park A; Choi SJ; Park S; Kim SM; Lee HE; Joo M; Kim KK; Kim D; Chung DH; Im JB; Jung J; Shin SK; Oh BC; Choi C; Nam S; Lee DH
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas.
    Hojnik M; Frković Grazio S; Verdenik I; Rižner TL
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
    Knight LP; Primiano T; Groopman JD; Kensler TW; Sutter TR
    Carcinogenesis; 1999 Jul; 20(7):1215-23. PubMed ID: 10383892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression.
    Robinson K; Cao Z; Delfino K; Cao D; Rao K
    J Int Med Res; 2023 Jun; 51(6):3000605231179317. PubMed ID: 37389562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional studies of aldo-keto reductases in Saccharomyces cerevisiae.
    Chang Q; Griest TA; Harter TM; Petrash JM
    Biochim Biophys Acta; 2007 Mar; 1773(3):321-9. PubMed ID: 17140678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.
    Tang Z; Xia C; Huang R; Li X; Wang WC; Guo W; Duan L; Luo W; Cao D; Luo DX
    Int J Clin Exp Pathol; 2014; 7(7):3791-9. PubMed ID: 25120755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldo-keto reductase family 1 member B10 is regulated by nucleos(t)ide analogues for chronic hepatitis B.
    Orita N; Kawaguchi K; Honda M; Shimode T; Hayakawa N; Terashima T; Komura T; Nishikawa M; Horii R; Nio K; Shimakami T; Takatori H; Arai K; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S; Kagaya T; Yamashita T
    Biochem Biophys Res Commun; 2023 Sep; 674():133-139. PubMed ID: 37419034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells.
    Matsunaga T; Okumura N; Saito H; Morikawa Y; Suenami K; Hisamatsu A; Endo S; Ikari A
    Chem Biol Interact; 2020 Dec; 332():109295. PubMed ID: 33096057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retracted: The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9801756. PubMed ID: 37593684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a role for a mouse sperm surface aldo-keto reductase (AKR1B7) and its human analogue in the detoxification of the reactive aldehyde, acrolein.
    Jagoe WN; Howe K; O'Brien SC; Carroll J
    Andrologia; 2013 Oct; 45(5):326-31. PubMed ID: 22970857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.
    Chang TS; Lin HK; Rogers KA; Brame LS; Yeh MM; Yang Q; Fung KM
    Int J Clin Exp Pathol; 2013; 6(11):2419-29. PubMed ID: 24228104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: TTC7B Is a Novel Prognostic-Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide.
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9787264. PubMed ID: 37810555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.